Antidiabetic Drugs

1976 days ago, 602 views
PowerPoint PPT Presentation
Antidiabetic Drugs. Nursing 3703 Pharmacology By Linda Self. Diabetes Mellitus. Interminable systemic ailment described by metabolic and vascular anomalies Issue of starch digestion system Results from deficient creation or underutilization of insulin. Diabetes Mellitus.

Presentation Transcript

Slide 1

Antidiabetic Drugs Nursing 3703 Pharmacology By Linda Self

Slide 2

Diabetes Mellitus Chronic systemic malady described by metabolic and vascular irregularities Disorder of sugar digestion Results from deficient generation or underutilization of insulin

Slide 3

Diabetes Mellitus Characterized by glucosuria and hyperglycemia Two structures—Type 1 and Type 2 Type 1—persistent secretes no insulin. Cause is felt to be immune system. Sort 2-tolerant secretes lacking measures of insulin and insulin receptors are impervious to existent coursing insulin

Slide 4

Diabetes Mellitus Symptoms: hyperglycemia, glucosuria, polyuria, polydipsia, polyphagia, and perhaps tingling. Fasting blood glucose is higher than 126 Manifested by: weight reduction, shortcoming, expanded recurrence of diseases, poly's

Slide 5

Diabetes Mellitus Without intercession, huge complexities will result. Include: retinopathies, glaucoma, neuropathies, cardiovascular disease.PVD. Expanded occurrence of toxemia of pregnancy.

Slide 6

Pathophysiology Insulin discharged by beta cells Insulin ties with and enacts 80% of cells Liver, muscle, and fat cells are essential tissues for insulin activity With insulin receptor authoritative, cell films penetrable to glucose into the cells

Slide 7

Pathophysiology cont. Expanded cell penetrability likewise considers amino acids, unsaturated fats and electrolytes to enter cells Changes cause anabolism and repress catabolism

Slide 8

Pathophysiology cont. Starch digestion Insulin builds glucose transport into liver, skeletal muscle, fat tissue, the heart, and even uterus. Must be available for muscle and fat tissues to utilize glucose for vitality Insulin controls glucose digestion to create vitality for cell capacities

Slide 9

Pathophysiology cont. Fat Metabolism Insulin advances glucose into fat cells where it is separated One of breakdown items is A-glycerophosphate, consolidates with unsaturated fats which eventually shapes triglycerides This is the instrument by which insulin advances fat stockpiling

Slide 10

Fat Metabolism When insulin is inadequate with regards to, fat is discharged into the circulation system as free unsaturated fats. Blood groupings of triglycerides, cholesterol and phospholipids are likewise expanded

Slide 11

Protein Metabolism Insulin builds the aggregate sum of body protein by expanding transport of amino acids into cells and combining protein inside the cells Insulin potentiates the impacts of development hormone Lack of insulin causes protein breakdown into amino acids

Slide 12

Endogenous Insulin Glucose is the real jolt of insulin emission Oral glucose is more compelling than intravenous glucose since glucose in stomach related tract expands the arrival of gastrin, secretin, chlecystokinin, and gastric inhibitory peptide Also invigorates vagal action

Slide 13

Endogenous Insulin Other hormones that raise blood glucose levels include: Cortisol Glucagon Growth hormone Epinephrine Estrogen Progesterone

Slide 14

Endogenous Insulin Factors that restrain insulin discharge include: Hypoxia Hypothermia Stimulation of alpha adrenergic 2 receptors

Slide 15

Classification of Two Types of Diabetes Type 1 diabetes comes about because of an immune system issue that wrecks pancreatic beta cells Usually has sudden onset Associated with high occurrence of intricacies Requires exogenous insulin 10% of those with diabetes are sort I

Slide 16

Diabetic Ketoacidosis (DKA) Life-debilitating complexity happens with insulin inadequacy Glucose can't be utilized by body cells for vitality so fat is assembled for this reason Mobilized fat is then extricated by liver and separated into glycerol and unsaturated fats Fatty acids additionally separated into ketones

Slide 17

DKA Accumulation of ketones results in acidemia Attempts to cushion acidic H+occurs by ionic trade, intracellular potassium exits cells. H+ particles enter cells. Result is discharge of potassium in pee. Kidneys endeavor to cushion by discharging ketones Pulmonary endeavor to support by Kussmaul breathing

Slide 18

Clinical S/S of DKA Kussmaul breathing Nausea and regurgitating Thirst Polydipsia, polyphagia and polyuria Hypotension Tachycardia stun

Slide 19

Type 2 Diabetes Mellitus Characterized by hyperglycemia and insulin resistance Results from expanded creation of glucose by liver and diminished take-up of glucose in liver, muscle and fat cells Insulin resistance—higher than regular groupings of insulin are required

Slide 20

Type 2 Diabetes Mellitus Occurs at any age Gradual onset Less serious side effects at first Easier to control More MIs and strokes 90% of those with diabetes are Type 2 multifactorial

Slide 21

Hyperosmolar hyperglycemia nonketotic trance state (HHNC) Occurs in Type 2 Diabetes Because patient has some endogenous insulin, no ketosis creates Blood sugars can be >800-1000 Can bring about hypovolemic stun, renal issues, stroke, unconsciousness and even demise

Slide 22

Metabolic Syndrome or Syndrome X Comprised of an arrangement of hazard components which include: Central stomach adiposity (men midsection estimate more prominent than 40 inches, ladies more noteworthy than 35 inches Fasting triglycerides more prominent > or equivalent to 150 mg/dl HDL cholesterol (under 40 in men, under 50 mg/dl in ladies

Slide 23

Metabolic Syndrome cont. 4. Circulatory strain more prominent than or equivalent to 130/85 5. Fasting glucose more noteworthy than or equivalent to 110mg/dL Also have prothrombotic and proinflammatory propensities

Slide 24

Metabolic Syndrome cont. All elements are interrelated Obesity and absence of activity tend to prompt to insulin resistance Insulin resistance negatively affects lipid generation. Increment VLDL, LDL, TG and diminishing the HDL. Insulin resistance prompts to expanded insulin and glucose levels in blood.

Slide 25

Hypoglycemic Drugs Insulin bring down glucose levels by expanding glucose take-up by cells Indicated for Type 1 DM, regularly in Type 2 DM, in those with incessant pancreatitis, in those on TPN, to treat hyperkalemia (imbuement with dextrose and insulin) Available insulins are pork and human

Slide 26

Age-Related contemplations Type 1 DM in kids Consistent eating regimen, blood glucose observing, insulin infusions and exercise Blood sugar control basic to keep up ordinary development and advancement Infections and diseases can bring about wide vacillations

Slide 27

Type 1 DM in kids cont. Kids profoundly vulnerable to lack of hydration Rotation of destinations is essential Avoiding hypoglycemia is a noteworthy objective in babies and youthful youngsters d/t harming consequences for development and improvement

Slide 28

Type 1 DM in kids s/s of hypoglycemia include: hunger, sweating, tachcardia, fractiousness and dormancy.

Slide 29

Age related contemplations in more established grown-ups Close observing of blood glucose levels Visual impedance may influence their capacity to self manage medicine May have renal inadequacy so alert w/certain antidiabetic meds a worry Caution with metformin if renal disability Glitazones can incline to liquid maintenance and heart disappointment

Slide 30

Insulin Human insulin is synthetically indistinguishable to endogenous insulin however it is not gotten from the human pancreas Cannot be given orally Insulins contrast in onset and span of activity. Ultra-short, short, middle and long acting.

Slide 31

Rapid acting Insulin lispro (Humalog) or insulin aspart (Novolog) are exceptionally shorting acting insulins More powerful in diminishing post-prandial hyperglycemia Less prone to bring about hypoglycemia before the following dinner Onset is 15', tops in 1-3 hours, term is 3-5 hours

Slide 32

Insulin cont. Short acting Insulins Regular Iletin II, Humulin R, Novolin R May be given sub Q or IV May be given as a ceaseless IV trickle The main insulin that might be given IV Onset is ½ 60 minutes, pinnacle is 2-3 hours and term is 5-7 hours

Slide 33

Intermediate-acting Insulins Isophane insulin suspension (NPH, NPH Iletin II, Humulin N, Novolin N) Onset is 1-1.5 hours, tops in 8-12 hours and span is 18-24

Slide 34

Long-acting Insulin Extended insulin zinc suspension Onset is 4-8 hours, crests in 10-30 hours and length is 36+ hours

Slide 35

Insulins cont. Insulin Mixtures NPH 70/30 (Humulin or Novolin 70/30) Durations of activities same as individual segments

Slide 36

Insulins cont. Insulin Analogs Lispro and aspart as already portrayed Insulin glargine (Lantus)- once every day at sleep time. Onset is 1.1 hours, pinnacle is none, length is 24 hours Must not be weakened or blended with whatever other insulin or arrangements

Slide 37

Oral Hypoglycemic Drugs Five sorts used to treat Type 2 DM Sulfonylureas—most seasoned. Increment arrival of insulin. Additionally diminish generation of glucose in the liver, increment the quantity of insulin receptors and increment fringe utilization of glucose. Successful just if have working beta cells. Essential reaction is hypoglycemia

Slide 38

Sulfonylureas cont. Original are basically out of date Use 2 nd era specialists Are glipizide (Glucotrol), glyburide (Diabeta)and glimepiride (Amaryl) Can be utilized with metformin, glitazones, insulin or acarbones Caution w/renal or hepatic debilitation. Not utilized as a part of pregnancy.

Slide 39

Alpha glucosidase Inhibitors Acarbose (Precose) and miglitol (Glyset) repress alpha-glucosidase compounds (maltase, amylase, sucrase) in GI tract. Defers ingestion of complex CHO and straightforward sugars Can be consolidated treatment w/insulin or w/sulfonylurea Contraindicated in cirrhosis, malabsorption, extreme renal debilitation

Slide 40

Alpha-glucosidase Inhibitors Take at start of every supper Can bring about bloating and looseness of the bowels

Slide 41

Biguanides Metformin (Glucophage) builds the utilization of glucose by muscle and fat cells, diminishes hepatic glucose generation, and declines intestinal assimilation of glucose Does not bring about hypoglycemia May be utilized alone or in blend Contraindicated in liver or renal impedance. Can re